Johnson & Johnson Market Cap 2006-2021 | JNJ

Johnson & Johnson market cap history and chart from 2006 to 2021. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Johnson & Johnson market cap as of July 23, 2021 is $447.62B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $447.625B $82.584B
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
Stock Name Country Market Cap PE Ratio
Roche Holding AG (RHHBY) Switzerland $317.907B 0.00
Pfizer (PFE) United States $232.136B 14.55
Eli Lilly (LLY) United States $228.718B 29.63
Novartis AG (NVS) Switzerland $208.455B 15.13
Novo Nordisk (NVO) Denmark $207.740B 30.63
AbbVie (ABBV) United States $207.602B 10.65
Merck (MRK) United States $193.778B 13.13
AstraZeneca (AZN) United Kingdom $152.121B 25.20
Sanofi (SNY) $129.473B 15.03
GlaxoSmithKline (GSK) United Kingdom $105.630B 14.80
Bayer (BAYRY) Germany $58.945B 8.11
H Lundbeck (HLUYY) Denmark $6.108B 10.50
Innoviva (INVA) United States $1.360B 5.43